1e
19
1
49
2
2
18
1b
1d
18
28
5a
1d 4 3 3 3 2 4 b 1f
2 29
1d
25
Anand Shah
88
5a
Adjunct Professor of Medical Ethics and Health Policy
7
77
Department: Medical Ethics and Health Policy
4
1
b
1d 4 3 3 3 2 4 b 1f
13
Education:
21 7 BS 16 (Economics) c
28 Duke University, 2001.
21 8 MPH c
38 Harvard School of Public Health, 2008.
21 7 MD c
33 University of Pennsylvania, 2008.
c
3
3
3
3
8d
Permanent link21 7 BS 16 (Economics) c
28 Duke University, 2001.
21 8 MPH c
38 Harvard School of Public Health, 2008.
21 7 MD c
33 University of Pennsylvania, 2008.
c
2 29
21
1e
1d
24
2b
29
27
23
ce Kadakia KT, Pazdur R, Shah A: US Food and Drug Administration support for oncology drug development during COVID-19. JAMA Oncol 2021.
ac Shah A: Medicare needs to OK rule giving seniors access to FDA-approved medical devices. CNBC 2021.
be Kadakia KT and Shah A: Addressing antimicrobial resistance – the invisible pandemic. Health Affairs Forefront 2021.
bd Shah A, Marks P, Hahn S: Ensuring the safety and effectiveness of a COVID-19 vaccine. Health Affairs Forefront 2020.
e1 Shah A, Kadakia KT, Marks P, Cavazzoni P, Hahn S: FDA initiatives to accelerate the development of COVID-19 therapeutics. Health Affairs Forefront 2020.
bb Shah A, Shuren J, Hahn S: FDA support for expedited access to COVID-19 diagnostics. Health Affairs Forefront 2020.
8e Shah A and Hahn S: The FDA response to COVID-19 at six months: regulatory innovation in the 4a face of a pandemic. Health Affairs Forefront 2020.
b9 Hahn S and Shah A: Coronavirus vaccine search – here’s what we’re doing to defeat COVID-19. FOX News 2020.
ba Kadakia KT, Patel B, Shah A: Advancing digital health: FDA innovation during COVID-19. npj Digital Medicine 2020.
2c
7
1d
1f
Selected Publications
b4 Farber MB and Shah A: The FDA is at a crossroads for reducing tobacco-related disease and death. STAT 2022.ce Kadakia KT, Pazdur R, Shah A: US Food and Drug Administration support for oncology drug development during COVID-19. JAMA Oncol 2021.
ac Shah A: Medicare needs to OK rule giving seniors access to FDA-approved medical devices. CNBC 2021.
be Kadakia KT and Shah A: Addressing antimicrobial resistance – the invisible pandemic. Health Affairs Forefront 2021.
bd Shah A, Marks P, Hahn S: Ensuring the safety and effectiveness of a COVID-19 vaccine. Health Affairs Forefront 2020.
e1 Shah A, Kadakia KT, Marks P, Cavazzoni P, Hahn S: FDA initiatives to accelerate the development of COVID-19 therapeutics. Health Affairs Forefront 2020.
bb Shah A, Shuren J, Hahn S: FDA support for expedited access to COVID-19 diagnostics. Health Affairs Forefront 2020.
8e Shah A and Hahn S: The FDA response to COVID-19 at six months: regulatory innovation in the 4a face of a pandemic. Health Affairs Forefront 2020.
b9 Hahn S and Shah A: Coronavirus vaccine search – here’s what we’re doing to defeat COVID-19. FOX News 2020.
ba Kadakia KT, Patel B, Shah A: Advancing digital health: FDA innovation during COVID-19. npj Digital Medicine 2020.
2c